Talent Science™

​

Workforce volatility is the top unmanaged risk in biopharma, costing sites £5-15M annually, yet 89% of executives can't quantify it. Your most expensive, volatile asset — talent — remains unmeasured.

Critical shortages in automation, QA/QC and digital capabilities affect 70% of firms.

Traditional HR metrics can't predict risk or prove return on investment.

Workforce performance drives 23% of EBITDA variance, yet most executives operate blind.

​

Talent Science™ applies data-driven precision to human capital, measuring and optimising workforce performance with the same standards you apply to equipment and intellectual property.

​

Our clients typically see:

15-25% uplift in automation ROI

$5-15M annual risk reduction through volatility management

40-60% faster new hire productivity

2-5% EBITDA improvement within 12-18 months

​